This study, based on 667 patients with papillary thyroid carcinoma (PTC), integrated BRAF V600E mutation abundance with clinical data and developed multiple machine learning models to predict the risk of cervical lymph node metastasis (CLNM). This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.